Prophylactic treatment with a novel bioadhesive gel formulation containing aciclovir and tenofovir protects from HSV-2 infection

Formulation Development and Evaluation of Innovative Two-Polymer (SR-2P) Bioadhesive Vaginal Gel

(2014) Satheesh Podaralla et al.   AAPS PHARMSCITECH

Vaginally Delivered Tenofovir Disoproxil Fumarate Provides Greater Protection than Tenofovir against Genital Herpes in a Murine Model of Efficacy and Safety

(2013) Briana Nixon et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

An engineered HIV-1 gp41 trimeric coiled coil with increased stability and anti-HIV-1 activity: implication for developing anti-HIV microbicides

(2013) P. Tong et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Intravaginal ring eluting tenofovir disoproxil fumarate completely protects macaques from multiple vaginal simian-HIV challenges

(2013) J. M. Smith et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Antiviral and Immunological Effects of Tenofovir Microbicide in Vaginal Herpes Simplex Virus 2 Infection

(2012) Line Vibholm et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Overview of microbicides for the prevention of human immunodeficiency virus

(2012) Salim S. Abdool Karim et al.   BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY

Vaginal microbicides for reducing the risk of sexual acquisition of HIV infection in women: systematic review and meta-analysis

(2012) Jael Obiero et al.   BMC INFECTIOUS DISEASES

Intravaginal ring delivery of tenofovir disoproxil fumarate for prevention of HIV and herpes simplex virus infection

(2012) P. M. M. Mesquita et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

An Intravaginal Ring for the Simultaneous Delivery of Multiple Drugs

(2012) Marc M. Baum et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Pharmacokinetics of Tenofovir following Intravaginal and Intrarectal Administration of Tenofovir Gel to Rhesus Macaques

(2011) Jeremy Nuttall et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Zinc Acetate/Carrageenan Gels Exhibit Potent ActivityIn Vivoagainst High-Dose Herpes Simplex Virus 2 Vaginal and Rectal Challenge

(2011) José A. Fernández-Romero et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Simultaneous Delivery of Tenofovir and Acyclovir via an Intravaginal Ring

(2011) John A. Moss et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Tenofovir-based pre-exposure prophylaxis for HIV prevention

(2011) Connie Celum et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Topical microbicides to prevent the transmission of HIV: formulation gaps and challenges

(2011) Jim A. Turpin   Drug Delivery and Translational Research

Impact of Valency of a Glycoprotein B-Specific Monoclonal Antibody on Neutralization of Herpes Simplex Virus

(2010) A. Krawczyk et al.   JOURNAL OF VIROLOGY

Maleic anhydride-modified chicken ovalbumin as an effective and inexpensive anti-HIV microbicide candidate for prevention of HIV sexual transmission

(2010) Lin Li et al.   Retrovirology

Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women

(2010) Q. Abdool Karim et al.   SCIENCE

Contribution of sexually transmitted infections to the sexual transmission of HIV

(2010) Helen Ward et al.   Current Opinion in HIV and AIDS

Vaginal Drug Delivery Systems for HIV Prevention

(2009) Lisa Cencia Rohan et al.   AAPS Journal

Increased CCL2 Expression and Macrophage/Monocyte Migration During Microbicide-Induced Vaginal Irritation

(2009) Carsten Alt et al.   CURRENT HIV RESEARCH

Novel approaches in fighting herpes simplex virus infections

(2009) Sarah S Wilson et al.   Expert Review of Anti-Infective Therapy

Development of a Comprehensive Human Immunodeficiency Virus Type 1 Screening Algorithm for Discovery and Preclinical Testing of Topical Microbicides

(2008) C. Lackman-Smith et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Toxicity Profile of Lutein and Lutein Ester Isolated From Marigold Flowers (Tagetes erecta)

(2008) Kuzhuvelil Bhaskarannair Harikumar et al.   INTERNATIONAL JOURNAL OF TOXICOLOGY

Coinfection with Herpes Simplex Virus Type 2 Is Associated with Reduced HIV‐Specific T Cell Responses and Systemic Immune Activation

(2008) Prameet M. Sheth et al.   JOURNAL OF INFECTIOUS DISEASES